Anhui Anke Biotechnology specializes in the research, development, manufacturing, and marketing of biopharmaceutical products, including bio-engineered drugs and vaccines. Its main customer base includes healthcare institutions and providers globally, focusing on treatments for diseases such as hepatitis and various cancers.
2024 Revenue: Estimated $500 million
Employees: 1,000
Anhui Anke Biotechnology is one of the...
Anhui Anke Biotechnology is a company listed under the stock ticker 300009 (CN).
View the org chart displaying its 16 main executives
Create your alert
to follow the executive moves at Anhui Anke Biotechnology.
Anhui Anke Biotechnology has 2,337 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.